The Outcome of Using Long-Acting Insulin Glargine with Regular Insulin Infusion in Diabetic Ketoacidosis Patients with Renal Impairment: A Randomized Clinical Trial

Author(s):
Mona AmmarMona Ammar1,*, Eeman AboubakrEeman Aboubakr, Wael AbdelmoneimWael Abdelmoneim
1MD

Journal of Cellular & Molecular Anesthesia:Vol. 8, issue 2; e149686
Published online:Jun 30, 2023
Article type:Original Articles
How to Cite:Ammar M, Aboubakr E, Abdelmoneim W. The Outcome of Using Long-Acting Insulin Glargine with Regular Insulin Infusion in Diabetic Ketoacidosis Patients with Renal Impairment: A Randomized Clinical Trial. J Cell Mol Anesth. 2023;8(2):e149686. doi: https://doi.org/10.22037/jcma.v8i2.39294

Abstract

Similar Articles

13
Jan
2023

The Outcome of Using Long-Acting Insulin Glargine with Regular Insulin Infusion in Diabetic Ketoacidosis Patients with Renal Impairment: A Randomized Clinical Trial

Mona Ammar,
Eeman Aboubakr,
Wael Abdelmoneim

Ammar M, Aboubakr E, Abdelmoneim W. The Outcome of Using Long-Acting Insulin Glargine with Regular Insulin Infusion in Diabetic Ketoacidosis Patients with Renal Impairment: A Randomized Clinical Trial. J Cell Mol Anesth. 2023;8(3):e151430. doi: https://doi.org/10.22037/jcma.v8i2.39294

11
Mar
2024
Int J Endocrinol Metab

Evaluation of the Effects of Incorporating Long-Acting Subcutaneous Insulin Into the Standard Treatment Protocol for Diabetic Ketoacidosis in Children

Fatemeh Saffari,
Ali Homaei,
Venus Chegini,
Amir Javadi,
Victoria Chegini

Saffari F, Homaei A, Chegini V, Javadi A, Chegini V. Evaluation of the Effects of Incorporating Long-Acting Subcutaneous Insulin Into the Standard Treatment Protocol for Diabetic Ketoacidosis in Children. Int J Endocrinol Metab. 2024;22(1):e139684. doi: https://doi.org/10.5812/ijem-139684

3
Sep
2017

Effects of Once-Weekly Dulaglutide on Glycemic Control and Renal Function in Patients with Advanced-Stage Diabetic Nephropathy

Keiji Hirai,
Shigeki Imamura,
Susumu Ookawara,
Aizan Hirai,
Yoshiyuki Morishita

Hirai K, Imamura S, Ookawara S, Hirai A, Morishita Y. Effects of Once-Weekly Dulaglutide on Glycemic Control and Renal Function in Patients with Advanced-Stage Diabetic Nephropathy. Nephro-Urol Mon. 2017;9(5):e55058. doi: https://doi.org/10.5812/numonthly.55058

15
Feb
2014

A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus

Aria Setoodeh,
Parastoo Rostami,
Ali Rabbani,
Maryam Nakhaei-Moghadam,
Farnaz Najmi-Varzaneh,
Nima Rezaei

Setoodeh A, Rostami P, Rabbani A, Nakhaei-Moghadam M, Najmi-Varzaneh F, et al. A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus. Inn J Pediatr. 2014;24(2):. doi:

30
Sep
2013

Comparing the effect of treatment with insulin alone versus insulin plus sulfonylurea in type 2 diabetic patients

S Hashemipou,
S Pourmohammad,
L Ghanei,
N Esmailzadehha,
A Javadi

Hashemipou S, Pourmohammad S, Ghanei L, Esmailzadehha N, Javadi A. Comparing the effect of treatment with insulin alone versus insulin plus sulfonylurea in type 2 diabetic patients. J Inflamm Dis. 2024;17(2):e155751. doi:

Indexed in

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles